Skip to main content
BOFIK
    • Gene Editing
    • Epigenetic Reprogramming
    • Senolytics
    • Mitochondria & Metabolism
    • Regenerative Medicine
    • Drug Delivery
    • AI & Computational Biology
    • Clinical Trials
    • Biotech Business
    • Longevity Lifestyle
  • Latest
  • About
Subscribe
Menu
  • Home
  • Latest
  • Topics
  • Gene Editing
  • Epigenetic Reprogramming
  • Senolytics
  • Mitochondria & Metabolism
  • Regenerative Medicine
  • Drug Delivery
  • AI & Computational Biology
  • Clinical Trials
  • Biotech Business
  • Longevity Lifestyle
  • About
Home / Latest / 2022

Articles from 2022

5 articles

June 13, 2022
NAD+ Precursor NMN Improves Muscle Function in Clinical Trial
Mitochondria & Metabolism

NAD+ Precursor NMN Improves Muscle Function in Clinical Trial

The first rigorous human trial of NMN supplementation shows meaningful benefits for age-related muscle decline.

Dr. Anna Kowalski Dr. Anna Kowalski 6 min read
April 21, 2022
New Epigenetic Clock Measures Biological Age with Unprecedented Precision
Epigenetic Reprogramming

New Epigenetic Clock Measures Biological Age with Unprecedented Precision

Fourth-generation aging clock can predict mortality risk and response to interventions with remarkable accuracy.

James Park James Park 6 min read
February 28, 2022
Machine Learning Identifies New Longevity Drug Candidates in Days
AI & Computational Biology

Machine Learning Identifies New Longevity Drug Candidates in Days

AI platform screens billions of compounds to find promising senolytic molecules, compressing years of drug discovery into weeks.

Dr. Anna Kowalski Dr. Anna Kowalski 5 min read
January 19, 2022
Altos Labs Emerges from Stealth with $3 Billion and Star-Studded Team
Biotech Business

Altos Labs Emerges from Stealth with $3 Billion and Star-Studded Team

The cellular rejuvenation startup backed by Jeff Bezos reveals its ambitious mission to reverse aging using reprogramming technology.

James Park James Park 6 min read
January 5, 2022
Longevity Startups Raised Record $5.2 Billion in 2021
Biotech Business

Longevity Startups Raised Record $5.2 Billion in 2021

Investment in aging research continues to surge as institutional investors recognize the massive market opportunity.

Marcus Rodriguez, MSc Marcus Rodriguez, MSc 5 min read

Archive

  • 2026
    • January 7
  • 2024
    • September 1
    • May 1
    • March 1
  • 2023
    • December 1
    • November 1
    • October 1
    • September 1
    • August 1
    • July 1
    • June 1
    • April 1
    • March 1
    • January 1
  • 2022
    • June 1
    • April 1
    • February 1
    • January 2
  • 2019
    • January 1
  • 2018
    • July 1

Newsletter

Get the latest bioengineering news in your inbox.

Stay Ahead of the Curve

Get the latest bioengineering and longevity news delivered to your inbox. No spam, unsubscribe anytime.

BOFIK

The Future of Human Longevity

Topics

  • Gene Editing
  • Epigenetic Reprogramming
  • Senolytics
  • Mitochondria & Metabolism
  • Regenerative Medicine
  • Drug Delivery

Company

  • About Us
  • Editorial Team
  • Contact
  • RSS Feed

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy

© 2026 BOFIK. All rights reserved.